Incannex Healthcare (IXHL) Accumulated Expenses (2020 - 2026)
Incannex Healthcare (IXHL) posted Accumulated Expenses of $1.6 million for Q1 2026, up 29.94% sequentially from $1.3 million in Q4 2025, and down 65.41% YoY from $4.7 million in Q1 2025.
Incannex Healthcare (IXHL) Accumulated Expenses (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Accumulated Expenses for 7 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Accumulated Expenses fell 65.41% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 65.41% YoY) and the FY2025 annual result came in at $6.1 million, up 25.99% from the prior year.
- Accumulated Expenses rose to $1.6 million in Q1 2026 per IXHL's latest filing, from $1.3 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $7.5 million in Q3 2024 and troughed at $415449.0 in Q2 2022.
- A 5-year average of $2.9 million and a median of $1.5 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses jumped 603.19% in 2024, then tumbled 82.69% in 2025.
- Over 5 years, Accumulated Expenses stood at $415449.0 in 2022, then surged by 156.35% to $1.1 million in 2023, then surged by 222.54% to $3.4 million in 2024, then sank by 63.44% to $1.3 million in 2025, then rose by 29.94% to $1.6 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $1.6 million, $1.3 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Incannex Healthcare | 41.61 Mn | 41.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 4.72 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 7.49 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.07 Mn |
| Jun 30, 2023 | 689,000.00 |
| Jun 30, 2022 | 415,449.00 |
| Jun 30, 2021 | 381,717.00 |
| Jun 30, 2020 | 316,046.00 |